The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Pharma Mar’s lurbinectedin (Zepzelca) to treat ...

Closing the critical gap between HCPs’ need for information and the pharma industry’s ability to deliver relevant, tailored ...

Celebrating the Communiqué Awards 2026!; Forging a connection with patients through creativity; GLP-1s and the consumer lifestyle shift ...

Eli Lilly and InnoCare Pharma, a biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, have ...

Explore why long-term clinical trial engagement is a behavioural challenge, showing how proactive support from site teams can ...

Trixeo is the first and only triple-combination therapy approved in the EU for patients 12 years and older, independent of ...

CSL Seqirus has announced a strengthened partnership with the UK government that will see the UK become the first country in ...

The SAB brings together leading global experts with complementary expertise across Alzheimer’s disease biology, biomarkers, ...

As the oncology landscape continues to evolve, life sciences organizations face a growing challenge: how do you communicate ...

The Emmes Group’s Board of Directors has appointed Rama Kondru as CEO. Kondru joined the Emmes Group in 2024 and most recently served as CEO of Veridix, the company’s AI, technology, and data sciences ...

If approved, this would be the first IL-17A inhibitor licensed in Europe for adults with polymyalgia rheumatica ...